Is hyperuricemia another facet of the metabolic syndrome?

Journal of the Chinese Medical Association

Volumn 69, Issue 3, 2006, Pages 104-109

  Liou, Teh Ling ^a   Lin, Ming Wei ^b   Hsiao, Li Chuan ^a   Tsai, Ting Ting ^a   Chan, Wan Leong ^a,b   Ho, Low Tone ^a,b   Hwu, Chii Min ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Factor analysis; Hyperuricemia; Metabolic syndrome; Obesity

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIVER ENZYME; TRIACYLGLYCEROL; URIC ACID;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FACTORIAL ANALYSIS; HUMAN; HYPERURICEMIA; LOGISTIC REGRESSION ANALYSIS; MALE; METABOLIC SYNDROME X; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; SYSTOLIC BLOOD PRESSURE; VARIANCE; WAIST CIRCUMFERENCE;

EID: 33645357294     PISSN: 17264901     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1726-4901(09)70186-8     Document Type: Article

References (25)

1. Modan M, Halkin H, Karasik A, Lusky A. Elevated serum uric acid - a facet of hyperinsulinaemia. Diabetologia 1987;30: 713-8.
2. Schmidt MI, Watson RL, Duncan BB, Metcalf P, Brancati F, Sharret AR, Davis CE, et al. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Metabolism 1996;45:699-706.
3. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, et al. Diagnosis and management of the metabolic sydrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52.
4. Lakka H-M, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-16.
5. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality. The NHANES I Epidemiologic Follow-up Study, 1971-1992. JAMA 2000;283:2404-10.
6. Liese AD, Hense H-W, Löwel H, Döring A, Tietze M, Keil U. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. Epidemiology 1999;10:391-7.
7. Zavaroni I, Mazza S, Fantuzzi M, Dall'Aglio E, Bonora E, Delsignore R, Passeri M, et al. Changes in insulin and lipid metabolism in males with asymptomatic hyperuricemia. J Intern Med 1993;234:25-30.
8. Klein BEK, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 2002;25:1790-4.
9. Bonora E, Targher G, Zenere MB, Saggiani F, Cacciatori V, Tosi F, Travia D, et al. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Related Metab Disord 1996;20: 975-80.
10. Clausen JO, Borch-Johnsen K, Ibsen H, Pedersen O. Analysis of the relationship between fasting serum uric acid and the insulin sensitivity index in a population-based sample of 380 young healthy Caucasians. Eur J Endocrinol 1998;138:63-9.
11. Hwu CM, Fuh JL, Hsiao CF, Wang SJ, Lu SR, Wei MC, Kao WY, et al. Waist circumference predicts metabolic cardiovascular risk in postmenopausal Chinese women. Menopause 2003;10: 73-80.
12. Hwu CM, Kwok CF, Kuo CS, Hsiao LC, Lee YS, Wei MJ, Kao WY, et al. Exacerbation of insulin resistance and postprandial triglyceride response in newly diagnosed hypertensive patients with hypertriglyceridemia. J Hum Hypertens 2002;16:487-93.
13. Lin KC, Lin HY, Chou P. Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. J Rheumatol 2000;27:1045-50.
14. World Health Organization/International Association for the Study of Obesity/International Obesity Taskforce. The Asia-Pacific perspective: redefining obesity and its treatment. Available at: http://www.diabetes.com.au/pdf/obesity_report.pdf. Accessed October 31, 2005.
15. Grundy SM, Brewer B Jr, Cleeman JI, Smith SC Jr, Lenfant C, for the Conference Participants. Definition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-8.
16. American Association of Clinical Endocrinologists. New ICD-9-CM code for dysmetabolic syndrome X. Available at: http://www.aace.com/members/socio/syndromex.php. Accessed October 31, 2005.
17. Yano K, Rhoads GG, Kagan A. Epidemiology of serum uric acid among 8000 Japanese American men in Hawaii. J Chron Dis 1977;30:171-84.
18. Meigs JB. Invited commentary: Insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 2000;152:908-11.
19. Leyva F, Godsland IF, Worthington M, Walton C, Stevenson JC. Factors of the metabolic syndrome. Baseline interrelationships in the first follow-up cohort of the HDDRISC Study (HDDRISC-1). Arterioscler Thromb Vasc Biol 1998;18:208-14.
20. Donahue RP, Bean JA, Donahue RD, Goldberg RB, Prineas RJ. Does insulin resistance unite the separate components of the insulin resistance syndrome? Evidence from the Miami Community Health Study. Arterioscler Thromb Vasc Biol 1997; 17:2413-7.
21. Hodge AM, Boyko EJ, de Courten M, Zimmet PZ, Chitson P, Tuomilehto J, Alberti KGM. Leptin and other components of the metabolic svndrome in Mauritius - a factor analysis. Int J Obes Relat Metab Disord 2001;25:126-31.
22. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003;98:960-7.
23. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346:1221-31.
24. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, et al. Nonalcoholic fatty liver disease. A feature of the metabolic syndrome. Diabetes 2001; 50:1844-50.
25. Teh BH, Pan WH, Chen CJ. The reallocation of body fat toward the abdomen persists to very old age, while body mass index declines after middle age in Chinese. Int J Obes Related Metab Disord 1996;20:683-7.